SELENOF and neoplasm: In conclusion, the data provided here indicates that SELENOF is a prostate cancer tumor suppressor able to alter the transformed phenotype of human prostate epithelial cells and may contribute to the disparity in prostate cancer mortality that exists among men of African descent.